711 related articles for article (PubMed ID: 29874998)
1. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
[TBL] [Abstract][Full Text] [Related]
2. Chemical strategies for pancreatic β cell differentiation, reprogramming, and regeneration.
Ma X; Zhu S
Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):289-301. PubMed ID: 28338772
[TBL] [Abstract][Full Text] [Related]
3. Pluripotent stem cell-derived pancreatic β-cells: potential for regenerative medicine in diabetes.
Kao DI; Chen S
Regen Med; 2012 Jul; 7(4):583-93. PubMed ID: 22817630
[TBL] [Abstract][Full Text] [Related]
4. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
Bose B; Katikireddy KR; Shenoy PS
Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
[TBL] [Abstract][Full Text] [Related]
5. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
[TBL] [Abstract][Full Text] [Related]
6. Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors.
Walczak MP; Drozd AM; Stoczynska-Fidelus E; Rieske P; Grzela DP
J Transl Med; 2016 Dec; 14(1):341. PubMed ID: 27998294
[TBL] [Abstract][Full Text] [Related]
7. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages.
Li K; Zhu S; Russ HA; Xu S; Xu T; Zhang Y; Ma T; Hebrok M; Ding S
Cell Stem Cell; 2014 Feb; 14(2):228-36. PubMed ID: 24506886
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
Bose B; Sudheer PS
Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
Quiskamp N; Bruin JE; Kieffer TJ
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
Agrawal A; Narayan G; Gogoi R; Thummer RP
Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
[TBL] [Abstract][Full Text] [Related]
12. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
13. A high-content small molecule screen identifies novel inducers of definitive endoderm.
Korostylev A; Mahaddalkar PU; Keminer O; Hadian K; Schorpp K; Gribbon P; Lickert H
Mol Metab; 2017 Jul; 6(7):640-650. PubMed ID: 28702321
[TBL] [Abstract][Full Text] [Related]
14. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
[TBL] [Abstract][Full Text] [Related]
15. Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.
Kunisada Y; Tsubooka-Yamazoe N; Shoji M; Hosoya M
Stem Cell Res; 2012 Mar; 8(2):274-84. PubMed ID: 22056147
[TBL] [Abstract][Full Text] [Related]
16. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
Cierpka-Kmiec K; Wronska A; Kmiec Z
Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line.
Pellegrini S; Manenti F; Chimienti R; Nano R; Ottoboni L; Ruffini F; Martino G; Ravassard P; Piemonti L; Sordi V
Cell Transplant; 2018 Oct; 27(10):1548-1560. PubMed ID: 30251567
[TBL] [Abstract][Full Text] [Related]
18. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
Liew CG
Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]